TITLE:
Anecortave Acetate in Subfoveal Choroidal Neovascularization (CNV) Due to Wet Age-Related Macular Degeneration (AMD)

CONDITION:
Macular Degeneration

INTERVENTION:
Anecortave Acetate 15 mg sterile suspension

SUMMARY:

      The purpose of this study was to evaluate anecortave acetate compared to placebo for
      maintenance of visual acuity after 24 months of treatment in patients with subfovial
      choroidal neovascularization (CNV) due to exudative age-related macular degeneration (AMD).
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 50 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Diagnosis of exudative AMD and a primary or recurrent subfoveal CNV lesion in the
             study eye.

          -  Other protocol-defined inclusion criteria may apply.

        Exclusion Criteria:

          -  Under 50 years.

          -  Other protocol-defined exclusion criteria may apply.
      
